EXCHANGE AGREEMENTExchange Agreement • May 10th, 2017 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2017 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (the “Agreement”), dated as of May [ ], 2017 (the “Effective Date”), is made by and between MabVax Therapeutics Holdings, Inc., a Delaware corporation (“Company”), and the holder of the Company’s Series H Preferred Stock signatory hereto (“Holder”).